![Brenda Reynolds](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brenda Reynolds
Direktor/Vorstandsmitglied bei
iQur Ltd.
Profil
Brenda Elizabeth Reynolds is the founder of PowderMed Ltd. (founded in 2004), Convergence Pharmaceuticals Ltd. (founded in 2010), and Calchan Ltd. (founded in 2011).
She held the title of Chief Operating Officer at PowderMed Ltd. from 2004 to 2008.
Dr. Reynolds currently holds multiple non-executive director positions at iQur Ltd., D3tex Ltd., Adiga Life Sciences, Inc., BQR Consulting Ltd., and Pleco Therapeutics BV.
She is also the owner of Questrax Ltd. Dr. Reynolds received an undergraduate degree from the University of Surrey.
Aktive Positionen von Brenda Reynolds
| Unternehmen | Position | Beginn |
|---|---|---|
iQur Ltd.
 iQur Ltd. BiotechnologyHealth Technology Develops vaccines | Direktor/Vorstandsmitglied | - |
Questrax Ltd. | Corporate Officer/Principal | 20.08.2010 |
D3tex Ltd. | Direktor/Vorstandsmitglied | - |
BQR Consulting Ltd. | Direktor/Vorstandsmitglied | - |
Pleco Therapeutics BV
 Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides therapies that change the balance in the treatment of cancer | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Brenda Reynolds
| Unternehmen | Position | Ende |
|---|---|---|
Adiga Life Sciences, Inc.
 Adiga Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel immunotherapeutic products in which small components (peptides of allergen proteins are identified and administered in a regimen | Direktor/Vorstandsmitglied | 23.11.2024 |
PowderMed Ltd.
 PowderMed Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic products | Gründer | 24.10.2008 |
University of Birmingham Enterprise Ltd.
 University of Birmingham Enterprise Ltd. Investment ManagersFinance University of Birmingham Enterprise invests in companies located in the United Kingdom. The firm focuses on academic consulting services and technology service sectors. It participates financing for early stage capital transactions. | Private Equity Investor | - |
Calchan Ltd.
 Calchan Ltd. BiotechnologyHealth Technology Operates as a biotechnology company, which develops novel oral state dependent calcium channel modulators for chronic pain | Vorstandsvorsitzender | - |
| ░░░ ░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Brenda Reynolds
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
18
Beziehungen ersten Grades
21
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 21 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Develops pharmaceutical products | Health Technology |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products | Process Industries |
Scotia Holdings Plc
 Scotia Holdings Plc Miscellaneous Commercial ServicesCommercial Services Researches and develops bio-pharmaceuticals | Commercial Services |
PowderMed Ltd.
PowderMed Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic products | Health Technology |
University of Surrey
 University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Altimmune UK Ltd.
 Altimmune UK Ltd. BiotechnologyHealth Technology Develops vaccines for mutating viruses | Health Technology |
DC Biosciences Ltd.
 DC Biosciences Ltd. BiotechnologyHealth Technology Provides bioreagents and life science services | Health Technology |
iQur Ltd.
iQur Ltd. BiotechnologyHealth Technology Develops vaccines | Health Technology |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the development of new medicines based on antibody fragment technology | Commercial Services |
University of Birmingham Enterprise Ltd.
University of Birmingham Enterprise Ltd. Investment ManagersFinance University of Birmingham Enterprise invests in companies located in the United Kingdom. The firm focuses on academic consulting services and technology service sectors. It participates financing for early stage capital transactions. | Finance |
Questrax Ltd. | |
The Institute of Directors (United Kingdom)
 The Institute of Directors (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Operates as membership organisation that provides events, development courses, networking and expert advice | Commercial Services |
Convergence Pharmaceuticals Ltd.
 Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops neuropathic pain products | Health Technology |
Beecham Pharmaceuticals (UK) | |
Calchan Holdings Ltd.
 Calchan Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops novel oral state-dependent calcium channel (CaV 2.2) modulators for chronic pain | Health Technology |
D3tex Ltd. | |
Adiga Life Sciences, Inc.
Adiga Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel immunotherapeutic products in which small components (peptides of allergen proteins are identified and administered in a regimen | Health Technology |
BQR Consulting Ltd. | |
Calchan Ltd.
Calchan Ltd. BiotechnologyHealth Technology Operates as a biotechnology company, which develops novel oral state dependent calcium channel modulators for chronic pain | Health Technology |
Pleco Therapeutics BV
Pleco Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides therapies that change the balance in the treatment of cancer | Commercial Services |
